CDXSCODEXIS, INC.

Nasdaq codexis.com


$ 3.08 $ 0.18 (6.21 %)    

Monday, 29-Apr-2024 12:17:19 EDT
QQQ $ 432.44 $ -0.71 (-0.16 %)
DIA $ 383.22 $ 0.03 (0.01 %)
SPY $ 509.98 $ -0.23 (-0.05 %)
TLT $ 88.87 $ 0.20 (0.23 %)
GLD $ 217.18 $ 1.11 (0.51 %)
$ 2.66
$ 2.90
$ 3.07 x 100
$ 3.08 x 100
$ 2.90 - $ 3.08
$ 1.45 - $ 4.91
513,816
na
175.38M
$ 1.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-27-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-28-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-01-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-15-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-09-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-08-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-11-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-06-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-upgrades-codexis-to-buy-announces-9-price-target

Benchmark analyst Robert Wasserman upgrades Codexis (NASDAQ:CDXS) from Hold to Buy and announces $9 price target.

 recap-codexis-q4-earnings
Recap: Codexis Q4 Earnings
02/28/2024 21:35:36

 codexis-q4-2023-gaap-eps-010-beats-012-estimate-sales-2656m-beat-1990m-estimate

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 codexis-secures-40m-in-strategic-financing-deal-with-innovatus-capital-partners-to-further-strengthen-cash-position-ahead-of-key-milestones

Term loan agreement enables Company to accelerate development and enhance commercialization of ECO Synthesis™ manufacturing pla...

 codexis-clinches-deal-with-nestl-health-science-eyes-up-to-45m-milestone-in-epi-treatment-breakthrough

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potenti...

 codexis-announces-purchase-agreement-with-nestl-health-science-for-cdx-7108--under-the-terms-codexis-will-receive-up-to-45m-in-potential-milestone-payments-including-a-5m-upfront-payment-as-well-as-single-digit-net-sales-based-royalties

Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced it has entered into a purchase agreement wit...

 why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

 why-nxu-shares-are-trading-higher-by-around-42-here-are-20-stocks-moving-premarket

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining inv...

 codexis-announces-achievement-of-gram-scale-synthesis-with-its-eco-synthesis-platform-milestone-enables-codexis-engineers-to-model-the-manufacturing-process-for-rnai-therapeutics

Milestone enables Codexis engineers to model the manufacturing process for RNAi therapeutics Company remains on track to initia...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION